An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer.
bone metabolism biomarkers
metabolite biomarkers
metastatic prostate cancer
microRNA biomarkers
neuroendocrine biomarkers
serum biomarkers
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
31 Jul 2020
31 Jul 2020
Historique:
received:
01
07
2020
revised:
21
07
2020
accepted:
31
07
2020
entrez:
6
8
2020
pubmed:
6
8
2020
medline:
6
8
2020
Statut:
epublish
Résumé
Serum biomarkers are molecules produced by normal and abnormal cells. Prostate specific antigen (PSA) is an example of a serum biomarker used widely in the diagnosis and prognostication of prostate cancer. PSA has its limitations as it is organ- but not cancer-specific. The aim of this review is to summarize the current published data on the potential prognostic and predictive biomarkers in metastatic prostate cancer (mPC) that can be used in conjunction with PSA. These biomarkers include microRNAs, androgen receptor variants, bone metabolism, neuroendocrine and metabolite biomarkers, and could guide treatment selection and sequence in an era where we strive to personalized therapy.
Identifiants
pubmed: 32752137
pii: diagnostics10080549
doi: 10.3390/diagnostics10080549
pmc: PMC7459446
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Natl Cancer Inst. 2014 Apr;106(4):dju013
pubmed: 24565955
Prostate. 2011 Feb 15;71(3):326-31
pubmed: 20842666
BMC Urol. 2018 May 8;18(1):32
pubmed: 29739368
Acta Oncol. 2011 Jun;50 Suppl 1:76-84
pubmed: 21604944
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):16-27
pubmed: 26667886
Br J Cancer. 2012 Aug 21;107(5):840-6
pubmed: 22871886
Histol Histopathol. 2015 Dec;30(12):1379-96
pubmed: 26186079
BJU Int. 2012 Feb;109(3):394-400
pubmed: 21599822
Diagnostics (Basel). 2019 Dec 11;9(4):
pubmed: 31835700
Sci Rep. 2018 Oct 18;8(1):15442
pubmed: 30337589
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
pubmed: 18287387
N Engl J Med. 2014 Sep 11;371(11):1028-38
pubmed: 25184630
Prostate. 2019 May;79(6):567-573
pubmed: 30614033
Br J Cancer. 2013 Jun 25;108(12):2565-72
pubmed: 23722472
Br J Cancer. 2014 May 13;110(10):2462-71
pubmed: 24714754
Urol Oncol. 2012 Sep;30(5):607-13
pubmed: 20888271
Urology. 2010 Jun;75(6):1446-51
pubmed: 20206975
Expert Rev Mol Diagn. 2015;15(12):1567-76
pubmed: 26548550
Int J Mol Sci. 2017 Jul 28;18(8):
pubmed: 28788048
Urol Oncol. 2011 Mar-Apr;29(2):162-5
pubmed: 19450995
Ther Adv Med Oncol. 2017 Aug;9(8):565-573
pubmed: 28794807
Clin Lab. 2019 Jul 1;65(7):
pubmed: 31307177
J Huazhong Univ Sci Technolog Med Sci. 2013 Aug;33(4):559-562
pubmed: 23904377
Clin Cancer Res. 2012 Nov 1;18(21):5888-901
pubmed: 23072969
Anticancer Res. 2018 Sep;38(9):4987-4997
pubmed: 30194142
Front Biosci (Landmark Ed). 2016 Jan 01;21:328-42
pubmed: 26709776
Medicine (Baltimore). 2019 May;98(19):e15608
pubmed: 31083254
Eur Urol. 2011 Apr;59(4):604-12
pubmed: 21190792
Cancer Res. 2018 Apr 1;78(7):1833-1844
pubmed: 29437039
Int J Cancer. 2011 Feb 1;128(3):608-16
pubmed: 20473869
Oncol Rep. 2012 Aug;28(2):409-17
pubmed: 22641253
Prostate. 2014 Dec;74(16):1691-6
pubmed: 25262981
Prostate. 2013 Mar;73(4):346-54
pubmed: 22887127
Prostate. 2018 Sep;78(12):927-937
pubmed: 29748958
BJU Int. 2017 Aug;120(2):226-232
pubmed: 28107595
Asian J Androl. 2013 Mar;15(2):231-5
pubmed: 23377530
Endocr Relat Cancer. 2014 May 08;21(3):487-93
pubmed: 24741024
J Investig Med. 2010 Dec;58(8):957-60
pubmed: 20818262
Urol Int. 2009;82(2):147-51
pubmed: 19321999
Int J Cancer. 2019 Dec 15;145(12):3231-3243
pubmed: 30779128
Future Oncol. 2013 Jun;9(6):899-907
pubmed: 23718310
BMC Med. 2017 Jul 5;15(1):122
pubmed: 28676103
Neoplasia. 2013 May;15(5):491-501
pubmed: 23633921
Prostate Cancer Prostatic Dis. 2018 Sep;21(3):431-437
pubmed: 29858590
BJU Int. 2017 Jan;119(1):30-37
pubmed: 27037533
Biochim Biophys Acta. 2014 Dec;1846(2):425-38
pubmed: 25220832
BMC Urol. 2017 Mar 20;17(1):18
pubmed: 28320379
Carcinogenesis. 2019 Jul 4;40(5):633-642
pubmed: 30874288
PLoS One. 2011;6(8):e22486
pubmed: 21853037
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Br J Cancer. 2012 Feb 14;106(4):768-74
pubmed: 22240788
J Urol. 2007 Sep;178(3 Pt 1):838-43; quiz 1129
pubmed: 17631319
J Clin Oncol. 2017 Jul 1;35(19):2149-2156
pubmed: 28384066
Cancer Inform. 2019 Mar 13;18:1176935119835522
pubmed: 30890858
Oncol Res Treat. 2019;42(4):165-185
pubmed: 30870834